Cargando…
Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis
BACKGROUND: In recent years, the U.S. government has designated funding of several large-scale initiatives for comparative effectiveness research (CER) in health care. The American Recovery and Reinvestment Act (ARRA) of 2009 apportioned more than $1 billion to support CER programs administered by t...
Autores principales: | Oderda, Gary M., Balfe, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442893/ https://www.ncbi.nlm.nih.gov/pubmed/22073936 http://dx.doi.org/10.18553/jmcp.2011.17.s9-b.S19 |
Ejemplares similares
-
Bringing Liraglutide to Market: A CER Case Study
por: Oderda, Gary, et al.
Publicado: (2012) -
Implementing CER: What Will It Take?
por: Biskupiak, Joseph E., et al.
Publicado: (2012) -
Looking at CER from Medicare’s Perspective
por: Mohr, Penny
Publicado: (2012) -
Looking at CER from the Pharmaceutical Industry Perspective
por: Dubois, Robert W.
Publicado: (2012) -
Looking at CER from the Managed Care Organization Perspective
por: Cannon, H. Eric
Publicado: (2012)